PTJ
HURA

Paul Tudor Jones’s TuHURA Biosciences HURA Stock Holding History

Paul Tudor Jones’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
+45,115
New +$105K ﹤0.01% 3407

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Paul Tudor Jones's HURA Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 45,115 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #3407 among its holdings.

90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Paul Tudor Jones held 45,115 shares of TuHURA Biosciences worth $106K as of Q2 2026.
  • TuHURA Biosciences was a new Paul Tudor Jones position in Q2 2026.
  • TuHURA Biosciences made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3407 holding.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.